More women with EARLY breast cancer will be treated with an aromatase inhibitor
January 2005
More women with EARLY breast cancer will be treated with an aromatase inhibitor...Arimidex, Femara, Aromasin.
Until now, tamoxifen was the "gold standard" to prevent recurrence in early estrogen receptor-positive breast cancer.
Experts now recommend most postmenopausal women should get an aromatase inhibitor...either initially or after receiving tamoxifen.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive